Business
MGC Pharma strikes exclusive world-wide product distribution agreement – Stockhead
Three-year deal with Swiss PharmaCan is for world-wide distribution of its anti-inflammatory product ‘We are very happy with the successful cooperation between…
Link copied toclipboard
- Three-year deal with Swiss PharmaCan is for world-wide distribution of its anti-inflammatory product
- ‘We are very happy with the successful cooperation between MGC and Swiss PharmaCan’ – Swiss PharmaCan CEO
- MGC Pharma to dispatch 40,000 units per quarter of its product to Swiss PharmaCan
Biopharma company MGC Pharmaceuticals (ASX:MXC) has stuck a worldwide supply and distribution agreement for its anti-inflammatory medicinal cannabis product that can be used to treat COVID-19.
…
-
Noosa News21 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News23 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
Noosa News23 hours agoGabby Petito died after experiencing domestic violence. Young Aussies are identifying with her story
-
General23 hours agoNo ‘band-aid solution’: sweating coal risky business